Plexus Corp. $PLXS Stake Boosted by Connor Clark & Lunn Investment Management Ltd.

Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Plexus Corp. (NASDAQ:PLXS) by 74.6% during the second quarter, HoldingsChannel reports. The institutional investor owned 36,901 shares of the technology company’s stock after purchasing an additional 15,762 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Plexus were worth $4,993,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Huntington National Bank grew its holdings in shares of Plexus by 41.5% during the second quarter. Huntington National Bank now owns 324 shares of the technology company’s stock valued at $44,000 after purchasing an additional 95 shares during the last quarter. Banque Transatlantique SA acquired a new stake in Plexus in the first quarter worth $71,000. CWM LLC lifted its stake in Plexus by 65.7% in the second quarter. CWM LLC now owns 537 shares of the technology company’s stock valued at $73,000 after buying an additional 213 shares during the last quarter. N.E.W. Advisory Services LLC acquired a new position in shares of Plexus during the first quarter valued at $87,000. Finally, TD Private Client Wealth LLC boosted its stake in Plexus by 31.5% during the 2nd quarter. TD Private Client Wealth LLC now owns 676 shares of the technology company’s stock valued at $91,000 after purchasing an additional 162 shares during the period. 94.45% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Plexus

In other Plexus news, CFO Patrick John Jermain sold 2,000 shares of Plexus stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $143.53, for a total value of $287,060.00. Following the transaction, the chief financial officer owned 16,961 shares in the company, valued at approximately $2,434,412.33. The trade was a 10.55% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CEO Todd P. Kelsey sold 2,000 shares of the company’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $143.50, for a total value of $287,000.00. Following the completion of the transaction, the chief executive officer directly owned 60,714 shares in the company, valued at $8,712,459. This represents a 3.19% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 17,574 shares of company stock valued at $2,463,831. 1.76% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

PLXS has been the subject of a number of recent analyst reports. Stifel Nicolaus set a $150.00 price objective on Plexus in a report on Friday, October 24th. Sidoti cut Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price target for the company. in a research note on Friday, October 24th. Wall Street Zen cut shares of Plexus from a “strong-buy” rating to a “buy” rating in a research note on Sunday, October 19th. Needham & Company LLC upped their price objective on shares of Plexus from $158.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Plexus in a research note on Wednesday, October 8th. Two investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Plexus has a consensus rating of “Hold” and an average price target of $159.00.

Plexus Price Performance

Shares of Plexus stock opened at $139.66 on Friday. The company has a current ratio of 1.58, a quick ratio of 0.77 and a debt-to-equity ratio of 0.06. The company’s 50-day moving average price is $143.16 and its two-hundred day moving average price is $135.92. Plexus Corp. has a 52 week low of $103.43 and a 52 week high of $172.89. The stock has a market cap of $3.77 billion, a PE ratio of 22.31 and a beta of 0.80.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, October 22nd. The technology company reported $2.14 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.30. The company had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. Plexus had a net margin of 4.29% and a return on equity of 12.77%. Plexus’s revenue was up .7% on a year-over-year basis. During the same period in the prior year, the company earned $1.85 EPS. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. As a group, sell-side analysts anticipate that Plexus Corp. will post 5.9 EPS for the current fiscal year.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.